The Incidence of HBV and HCV Infection in Australian Travelers to Asia

被引：11
|
作者：
Johnson, Douglas F. [1 ,2 ]
Ratnam, Irani [3 ]
Matchett, Elizabeth [3 ]
Earnest-Silveria, Linda [1 ]
Christiansen, Dale [1 ]
Leder, Karin [3 ,4 ]
Grayson, Michael L. [1 ,2 ]
Torresi, Joseph [1 ,2 ]
机构：
[1] Univ Melbourne, Austin Hosp, Dept Infect Dis, Heidelberg, Vic, Australia
[2] Univ Melbourne, Austin Hosp, Dept Med, Heidelberg, Vic, Australia
[3] Royal Melbourne Hosp, Victorian Infect Dis Serv, Parkville, Vic 3050, Australia
[4] Monash Univ, Dept Epidemiol & Prevent Med, Clayton, Vic, Australia
来源：
JOURNAL OF TRAVEL MEDICINE | 2013年 / 20卷 / 03期
关键词：
HEPATITIS-B;
D O I：
10.1111/jtm.12029
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
We analyzed paired pre- and post-travel sera in a cohort of Australian travelers to Asia and demonstrated the acquisition of hepatitis C virus (HCV) and hepatitis B virus (HBV) infection. The incidence density in nonimmune travelers for HCV infection was calculated as 1.8 infections per 10,000 traveler-days and for HBV infection 2.19 per 10,000 traveler-days.
引用
收藏
页码：203 / 205
页数：3
相关论文
共 50 条
  • [21] HBV/HCV dual infection impacts viral load, antibody response, and cytokine expression differently from HBV or HCV single infection
    Chen, Fei
    Zhang, Jian
    Wen, Bo
    Luo, Shan
    Lin, Yingbiao
    Ou, Wensheng
    Guo, Fengfan
    Tang, Ping
    Liu, Wenpei
    Qu, Xiaowang
    SCIENTIFIC REPORTS, 2016, 6
  • [22] Incidence of HCV infection in an Egyptian village
    Bakr, I.
    El-Houssinie, M.
    Arafa, N.
    El-Daly, M.
    El-Kafrawy, S.
    Abdel-Hamid, M.
    Rekacewicz, C.
    Fontanet, A.
    Mohamed, M. K.
    LIVER INTERNATIONAL, 2006, 26 : 75 - 76
  • [23] Management of rheumatic disease with comorbid HBV or HCV infection
    Vassilopoulos, Dimitrios
    Calabrese, Leonard H.
    NATURE REVIEWS RHEUMATOLOGY, 2012, 8 (06) : 348 - 357
  • [24] HCV IN NON-REPLICATIVE CHRONIC HBV INFECTION
    SMITH, HM
    DANIELS, HM
    TIBBS, CJ
    LAU, JYN
    WILLIAMS, R
    JOURNAL OF HEPATOLOGY, 1992, 14 (2-3) : 405 - 405
  • [25] Ledipasvir and sofosbuvir for HCV infection in patients coinfected with HBV
    Gane, Edward J.
    Hyland, Robert H.
    An, Di
    Svarovskaia, Evguenia S.
    Brainard, Diana
    McHutchison, John G.
    ANTIVIRAL THERAPY, 2016, 21 (07) : 605 - 609
  • [26] A study of arteriosclerosis in healthy subjects with HBV and HCV infection
    Moritani, M
    Adachi, K
    Arima, N
    Takashima, T
    Miyaoka, Y
    Niigaki, M
    Furuta, K
    Sato, S
    Kinoshita, Y
    JOURNAL OF GASTROENTEROLOGY, 2005, 40 (11) : 1049 - 1053
  • [27] A comparison of hepatocellular carcinoma associated with HBV or HCV infection
    Tanabe, G
    Nuruki, K
    Baba, Y
    Imamura, Y
    Miyazono, N
    Ueno, K
    Arima, T
    Nakajyou, M
    Aikou, T
    HEPATO-GASTROENTEROLOGY, 1999, 46 (28) : 2442 - 2446
  • [28] HBV and HCV infection before and after kidney transplantation
    Gorgi, Y
    Ayed, K
    Ben Abdallah, T
    Kammoun, A
    Ben Maïz, H
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (05) : 2856 - 2857
  • [29] A study of arteriosclerosis in healthy subjects with HBV and HCV infection
    Makoto Moritani
    Kyoichi Adachi
    Noriyuki Arima
    Toshiharu Takashima
    Youichi Miyaoka
    Masatoshi Niigaki
    Kenji Furuta
    Shuichi Sato
    Yoshikazu Kinoshita
    Journal of Gastroenterology, 2005, 40 : 1049 - 1053
  • [30] Immunological and technical prevention of infection with HBV, HCV and HIV
    Hofmann, F.
    Wittmann, A.
    Kralj, N.
    Schroebler, S.
    Gasthaus, K.
    ANASTHESIOLOGIE & INTENSIVMEDIZIN, 2006, 47 : S39 - S43
12345